Form 4: Edwards Lifesciences Executive Daveen Chopra Reports Stock Disposal
SEC Form 4 Filing
Daveen Chopra, CVP at Edwards Lifesciences, reported the disposal of 580 shares of common stock on May 11, 2025, at a price of $73.68 per share.
Summary
- On May 11, 2025, Daveen Chopra, CVP, TMTT of Edwards Lifesciences Corp, disposed of 580 shares of common stock.
- The transaction was executed at a price of $73.68 per share.
- Following the transaction, Chopra directly owns 34,996 shares of Edwards Lifesciences common stock.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing regarding a stock transaction. It doesn't inherently indicate positive or negative sentiment about the company.
Industry Context
This is a routine disclosure of stock transactions by a company executive, which is common in the healthcare industry.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 05/11/2025 | Date of transaction: Daveen Chopra disposed of 580 shares of Edwards Lifesciences common stock. |
| 05/12/2025 | Date of signature by Linda J. Park, Attorney-in-Fact. |
Keywords
Form 4, Beneficial Ownership, Stock Disposal, Edwards Lifesciences, Chopra, Executive, Equity Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.